मुख्यपृष्ठ › प्रोस्टेट कर्करोग › वॉशिंग्टन › Seattle
Seattle, WA मधील प्रोस्टेट कर्करोग साठी क्लिनिकल ट्रायल्स
Seattle आणि आजूबाजूच्या ठिकाणी (सुमारे 30 मैलांच्या आत) प्रोस्टेट कर्करोग साठी 42 अभ्यास सहभागी शोधत आहेत. कोण सहभागी होऊ शकते आणि अभ्यास संघाशी संपर्क कसा साधावा हे पाहण्यासाठी अभ्यास उघडा.
अधिकृत अभ्यास मजकूर (इंग्रजी)
अभ्यासासाठी सहभागी शोधत आहात? हे पृष्ठ शीर्षस्थानी दर्शवा — 30 दिवसांसाठी $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
निवड सुरू आहेफेज 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- आणि आणखी 1
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
निवड सुरू आहेफेज 1
- Swedish Medical Center, Seattle
Precision-Based Genomics in Prostate Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- University of Washington, Seattle
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Research Center, Seattle
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Center, Seattle
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
निवड सुरू आहेफेज 2/3
- Fred Hutchinson Cancer Research Center, Seattle
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
निवड सुरू आहेफेज 3
- Swedish Medical Center, Seattle
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
निवड सुरू आहेफेज 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
निवड सुरू आहेफेज 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
निवड सुरू आहेफेज 3
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
निवड सुरू आहेनिरीक्षण अभ्यास
- University of Washington Medical Center, Seattle
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
निवड सुरू आहेफेज 2
- University of Washington, Seattle
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
निवड सुरू आहेफेज 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
निवड सुरू आहेफेज 1
- Investigational Site Number: 400, Seattle
Prostate Active Surveillance Study
निवड सुरू आहेनिरीक्षण अभ्यास
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
निवड सुरू आहेफेज 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
निवड सुरू आहेफेज 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
निवड सुरू आहेफेज 2
- University of Washington Medical Center, Seattle
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
निवड सुरू आहेफेज 2
- Fred Hutchinson Cancer Center, Seattle
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Center, Seattle
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
निवड सुरू आहेफेज 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- आणि आणखी 4
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
निवड सुरू आहेफेज 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
निवड सुरू आहेफेज 2
- Fred Hutchinson Cancer Center, Seattle
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Center, Seattle
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
निवड सुरू आहेफेज 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Center, Seattle
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
निवड सुरू आहेफेज 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
निवड सुरू आहे
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
निवड सुरू आहेफेज 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- आणि आणखी 4
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
निवड सुरू आहेफेज 1
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
निवड सुरू आहेफेज 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
निवड सुरू आहेफेज 2
- VA Puget Sound Health Care System, Seattle
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
निवड सुरू आहेनिरीक्षण अभ्यासस्वस्थ स्वयंसेवकांचे स्वागत आहे
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
निवड सुरू आहेफेज 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
निवड सुरू आहेफेज 1
- Fred Hutchinson Cancer Center, Seattle
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
निवड सुरू आहेफेज 2
- Swedish Medical Center-Ballard Campus, Seattle
- FHCC South Lake Union, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- आणि आणखी 4
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
निवड सुरू आहेनिरीक्षण अभ्यास
- Massive Bio SYNERGY-AI site, Seattle
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
निवड सुरू आहेफेज 3
- FHCC South Lake Union, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
इतर शहरांतील प्रोस्टेट कर्करोग ट्रायल्स
- New York City, NY103 अभ्यास
- Houston, TX76 अभ्यास
- Los Angeles, CA61 अभ्यास
- Boston, MA59 अभ्यास
- St. Louis, MO46 अभ्यास
- Chicago, IL45 अभ्यास
- San Francisco, CA45 अभ्यास
- Philadelphia, PA44 अभ्यास
- Baltimore, MD43 अभ्यास
- Nashville, TN42 अभ्यास
- Washington, DC38 अभ्यास
- Dallas, TX36 अभ्यास
Seattle मधील इतर अभ्यास
- नॉन-स्मॉल सेल लंग कॅन्सर53 अभ्यास
- कर्करोग (सर्व प्रकार)49 अभ्यास
- अ‍ॅक्युट मायलोइड ल्युकेमिया40 अभ्यास
- स्तनाचा कर्करोग39 अभ्यास
- मेटास्टॅटिक कर्करोग39 अभ्यास
- कोलोरॅक्टल कॅन्सर34 अभ्यास
- फुफ्फुसाचा कॅन्सर33 अभ्यास
- अंडाशयाचा कर्करोग30 अभ्यास
- मल्टिपल मायलोमा22 अभ्यास
- मायलोडिस्प्लास्टिक सिंड्रोम्स21 अभ्यास
- अ‍ॅक्युट लिम्फोब्लास्टिक ल्युकेमिया21 अभ्यास
- मूत्राशय कर्करोग21 अभ्यास
ClinicalTrials.gov वरून, 5 ऑक्टो, 2026 रोजी मिळालेली माहिती. प्रत्येक अभ्यासासाठी पात्रतेचे निकष वेगळे असतात; अभ्यास संघ ठरवतो की कोण सहभागी होऊ शकते.